Glucose-dependent insulinotropic peptide prevents aging associated bone loss.

被引:0
|
作者
Ding, K.
Xie, D.
Bollag, R. J.
Bollag, W.
Shi, X.
Hamrick, M.
Curl, W.
Isales, C. M.
机构
[1] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA
[2] Augusta VA Hosp, Augusta, GA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S208 / S208
页数:1
相关论文
共 50 条
  • [1] Impact of glucose-dependent insulinotropic peptide on age-induced bone loss
    Ding, Ke-Hong
    Shi, Xing-Ming
    Zhong, Qing
    Kang, Baolin
    Xie, Ding
    Bollag, Wendy B.
    Bollag, Roni J.
    Hill, William
    Washington, Walter
    Mi, Qing-Sheng
    Insogna, Karl
    Chutkan, Norman
    Harnrick, Mark
    Isales, Carlos M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (04) : 536 - 543
  • [2] Glucose-dependent insulinotropic peptide regulates bone turnover in vivo.
    Xie, D
    Ding, KH
    Hamrick, M
    Mulloy, AL
    Insogna, K
    Isales, CM
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S462 - S462
  • [3] Effects of glucose-dependent insulinotropic peptide on behavior
    Ding, Ke-Hong
    Zhong, Qing
    Xie, Ding
    Chen, Huan-Xin
    Della-Fera, Mary Anne
    Bollag, Roni J.
    Bollag, Wendy B.
    Gujral, Ravinder
    Kang, Baolin
    Sridhar, Supriya
    Baile, Clifton
    Curl, Walton
    Isales, Carlos M.
    PEPTIDES, 2006, 27 (11) : 2750 - 2755
  • [4] Effects of glucose-dependent insulinotropic peptide on osteoclast function
    Zhong, Qing
    Itokawa, Takashi
    Sridhar, Supriya
    Ding, Ke-Hong
    Xie, Ding
    Kang, Baolin
    Bollag, Wendy B.
    Bollag, Roni J.
    Hamrick, Mark
    Insogna, Karl
    Isales, Carlos M.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (02): : E543 - E548
  • [5] Glucose-dependent Insulinotropic Peptide Inhibits Glucose-induced Apoptosis of Bone Cells.
    Sridhar, S.
    Marrero, M.
    Shi, X.
    Sridhar, S.
    Mi, O.
    Bollag, W. B.
    Chutkan, N.
    Isales, C. M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S376 - S376
  • [6] Changes in bone density in transgenic mice overexpressing glucose-dependent insulinotropic peptide.
    Ding, K
    Cranford, J
    Zhong, O
    Mulloy, A
    New, K
    Isales, CM
    Bollag, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S426 - S426
  • [7] Glucose-dependent insulinotropic peptide impairs insulin signaling via inducing adipocyte inflammation in glucose-dependent insulinotropic peptide receptor-overexpressing adipocytes
    Nie, Yaohui
    Ma, Ronald C.
    Chan, Juliana C. N.
    Xu, Haiyan
    Xu, Gang
    FASEB JOURNAL, 2012, 26 (06): : 2383 - 2393
  • [8] Glucose-dependent insulinotropic peptide level is associated with the development of type 2 diabetes mellitus
    Suh, Sunghwan
    Lee, Jeehyun
    Bae, Ji Cheol
    Jin, Sang-Man
    Kim, Hyun Jin
    Won, Jong Chul
    Kim, Sang Yong
    Cho, Nam Han
    Lee, Moon-Kyu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S68 - S68
  • [9] Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects
    Bollag, RJ
    Zhong, Q
    Ding, KH
    Phillips, P
    Zhong, L
    Qin, F
    Cranford, J
    Mulloy, AL
    Cameron, R
    Isales, CM
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 177 (1-2) : 35 - 41
  • [10] Glucose-dependent insulinotropic peptide signaling pathways in endothelial cells
    Zhong, Q
    Bollag, RJ
    Dransfield, DT
    Gasalla-Herraiz, J
    Ding, KH
    Min, L
    Isales, CM
    PEPTIDES, 2000, 21 (09) : 1427 - 1432